Garden Leave Provisions in Employment Agreements: 2023 Update

Thomson Reuters Practical Law has released the 2023 update to “Garden Leave Provisions in Employment Agreements,” co-authored by our colleague Peter A. Steinmeyer and Lauri F. Rasnick. The Note discusses garden leave provisions in employment agreements as an alternative or a companion to traditional employee non-compete agreements. It addresses the differences between garden leave and […]

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Invivyd To Contact Him Directly To Discuss

NEW YORK, Feb. 11, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (“Invivyd” or the “Company”) (NASDAQ: IVVD) and reminds investors of the April 3, 2023 deadline to seek the role of lead plaintiff in a federal securities class […]

Preparing for Non-Compete Litigation: 2023 Update

Thomson Reuters Practical Law has released the 2023 update to “Preparing for Non-Compete Litigation,” co-authored by our colleague Peter A. Steinmeyer. Following is an excerpt (see below to download the full version in PDF format): Non-compete litigation is typically fast-paced and expensive. An employer must act quickly when it suspects that an employee or former […]

The Klein Law Firm Announces a Lead Plaintiff Deadline of April 3, 2023 in the Class Action Filed on Behalf of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc.

NEW YORK, Feb. 7, 2023 /PRNewswire/ — The Klein Law Firm announced that a class action complaint has been filed on behalf of shareholders of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (NASDAQ: IVVD) alleging that the Company violated federal securities laws. This lawsuit is on behalf of all purchasers of Adagio common stock between November […]